{"nctId":"NCT03568331","briefTitle":"Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)","startDateStruct":{"date":"2018-07-09","type":"ACTUAL"},"conditions":["Atopic Dermatitis"],"count":375,"armGroups":[{"label":"Tradipitant","type":"EXPERIMENTAL","interventionNames":["Drug: Tradipitant"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Tradipitant","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male and non-pregnant, non-lactating female patients aged 18 - 70 years (inclusive);\n* Diagnosed with atopic dermatitis;\n* Suffering from chronic pruritus;\n* Body Mass Index (BMI) of ≥18 and ≤40 kg/m2\n\nExclusion Criteria:\n\n* Chronic pruritus due to condition other than atopic dermatitis (AD);\n* A positive test for drugs of abuse at the screening or evaluation visits;\n* Exposure to any investigational medication in the past 8 weeks","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Reduction of Worst Itch in Atopic Dermatitis","description":"Reduction of worst itch in atopic dermatitis as measured by Numerical Rating Scale (NRS). Worst Itch NRS is an assessment tool that is used to report the maximum intensity of participant's itch during a 24-hour recall period. Participants were asked the following question: Please rate the itching severity that describes your worst level of itching in the past 24 hours \\[0=No Itch, 10=Worst Itch Imaginable\\].","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.6","spread":"2.8"},{"groupId":"OG001","value":"-3.5","spread":"2.75"}]}]}]},{"type":"SECONDARY","title":"Improvement of Disease Severity in Atopic Dermatitis","description":"Proportion of participants achieving 50% reduction on the SCORing Atopic Dermatitis (SCORAD) index. SCORAD is an assessment scale used to determine the severity of AD. SCORAD combines the investigator's rating of extent and intensity and the patient reported itch and sleep disturbance. Total score ranges from 0 (absent disease) to 103 (severe disease).","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"51","spread":null},{"groupId":"OG001","value":"54","spread":null}]}]}]},{"type":"SECONDARY","title":"Proportion of Patients With Improvement on Investigator Global Assessment for Atopic Dermatitis (vIGA-AD) of at Least 2-point Reduction","description":"As measured by the validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD). IGA is an assessment scale used to determine severity of AD. It is assessed by the investigator on a 5-point scale (0=clear, 1=almost clear, 2=mild, 3=moderate, 4=severe) based on erythema, induration/papulation, lichenification, and oozing/crusting.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"37","spread":null},{"groupId":"OG001","value":"36","spread":null}]}]}]},{"type":"POST_HOC","title":"Reduction of Worst Itch in Atopic Dermatitis as Measured by Numerical Rating Scale (NRS), Adjusted for Investigator Global Assessment (IGA)","description":"Worst Itch NRS is an assessment tool that is used to report the maximum intensity of participant's itch during a 24-hour recall period. Participants were asked the following question: Please rate the itching severity that describes your worst level of itching in the past 24 hours \\[0=No Itch, 10=Worst Itch Imaginable\\].","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.6","spread":null},{"groupId":"OG001","value":"-1.0","spread":null}]}]}]},{"type":"POST_HOC","title":"Reduction in Sleep Disturbances as Measured by SCORing Atopic Dermatitis Index, Adjusted for Investigator Global Assessment","description":"SCORAD is an assessment scale used to determine the severity of AD. SCORAD combines the investigator's rating of extent and intensity and the patient reported itch and sleep disturbance. Total score ranges from 0 (absent disease) to 103 (severe disease).","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.07","spread":null},{"groupId":"OG001","value":"-0.7","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2,"n":188},"commonTop":["Headache","Upper respiratory tract infection","Diarrhoea","Dermatitis atopic"]}}}